Collaboration combines Odyssey's disease biology expertise with Evotec's AI-enabled discovery platform, advanced screening capabilities and proprietary compound libraries to support advancement of Odyssey's discovery-stage programsEvotec to deliver validated hit series across multiple high-value targets for large inflammatory and…
- H1 2026 net sales, operating profit, and net income increased 27.2%, 8.4%, and 23.5% on-year, respectively- Strategic investments to support long-term growth amid the rollout of U.S. direct sales operations- Both medical aesthetics and cosmetics fuel balanced…
BEIJING, Aug. 5, 2026 /PRNewswire/ -- China's economic growth is undergoing a structural shift, with new and emerging technologies moving beyond a supporting role to become genuine drivers of growth. According to data released by China's National Bureau…
Dual designations support development of a potential first disease-modifying therapy for an ultra-rare neurometabolic disorderBOSTON, Aug. 5, 2026 /PRNewswire/ -- Galibra Neuroscience announced a significant regulatory milestone with the receipt of both Orphan Drug Designation (ODD) and Rare…
Experienced technology executive to lead Infor's next phase of growth in Japan, helping customers modernize operations through industry-specific cloud solutions, AI, and deep industry expertise.NEW YORK and TOKYO, Aug. 5, 2026 /PRNewswire/ -- Infor, the industry cloud company,…